Related Experiment Video
Updated: Mar 17, 2026
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
Stereotactic Body Radiotherapy for Spinal Metastases: Practice Guidelines, Outcomes, and Risks
Siavash Jabbari1, Peter C Gerszten, Mark Ruschin
1From the *Department of Radiation Oncology, The Laurel Amtower Cancer Institute and Neuro-oncology Center, Sharp Healthcare, San Diego, CA; †Department of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, PA; ‡Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; §Department of Radiation Oncology, University of California San Francisco, San Francisco, CA; and ∥Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH.
Spine stereotactic body radiotherapy offers improved treatment for spinal metastases compared to conventional methods. This advanced technique provides better local tumor control and palliative efficacy for selected patients.
Area of Science:
- Oncology
- Radiation Oncology
- Neurosurgery
Background:
- Spine metastases present significant therapeutic challenges in cancer care.
- Surgical interventions for spinal metastases are often limited by complexity and risks.
- Conventional external beam radiation therapy shows limited efficacy for palliative care and local tumor control.
Purpose of the Study:
- To review the current evidence for spine stereotactic body radiotherapy (SBRT) in managing spinal metastases.
- To discuss the understanding of late effects associated with SBRT for spinal metastases.
- To outline the technological requirements for implementing SBRT in spinal metastases treatment.
Main Methods:
- Review of current literature on spine stereotactic body radiotherapy for spinal metastases.
- Analysis of palliative efficacy and local tumor control data.
- Examination of technological advancements and quality metrics for SBRT delivery.
Main Results:
- Spine SBRT is emerging as a preferred modality for selected spinal metastases (de novo, postoperative, reirradiation).
- SBRT demonstrates superior palliative efficacy and local tumor control compared to conventional radiotherapy.
- Successful SBRT application requires specialized expertise, multidisciplinary collaboration, and strict quality adherence.
Conclusions:
- Spine SBRT is a highly conformal ablative therapy offering a promising treatment option for spinal metastases.
- Further research and adherence to quality metrics are essential for optimizing SBRT outcomes.
- This modality represents a significant advancement in the management of complex spinal metastases.
